NCT05209217View on ClinicalTrials.gov

Open Study of the Neurobiological Effects of Intranasal Ketamine in Children and Adults With Bipolar Disorder

UnknownOBSERVATIONAL
Enrollment

20

Participants

Timeline

Start Date

June 4, 2019

Primary Completion Date

December 31, 2022

Study Completion Date

January 15, 2023

Conditions
Bipolar Disorder
Interventions
DRUG

Ketamine

Intranasal administration of their customary prescribed dose

Trial Locations (1)

02478

RECRUITING

McLean Hospital, Belmont

Sponsors
All Listed Sponsors
collaborator

Juvenile Bipolar Research Foundation

OTHER

lead

Mclean Hospital

OTHER